IMB-401
Innovative Medicines based on
ImmunoModulatory Biologics
-
Pipeline
-
IMB-401
Confidential Information
To be disclosed when ongoing patent application is completed.
좌우로 스크롤 하시면 전체 내용을 확인할 수 있습니다.
- President(CEO) : Gyongsik Ha
- 260, Changnyong-daero, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea